bluebird bio, Inc. (BLUE) saw a big move last session, as the company’s shares fell by over 13% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for BLUE, as the stock is now down over 38% since Sep 18, 2015.
This slump shouldn’t be too much of a surprise to investors, as the biotechnology company’s current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
BLUE currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.
Investors interested in the same industry may consider better-ranked stock like Bally Anika Therapeutics Inc. (ANIK), which carries a Zacks Rank #1 (Strong Buy).
Is BLUE going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment